Fem Care Pharma Ltd merged Nine Monthly Results

Gross Sales

81.11

74.01

63.74

Excise Duty

0

0

0

Net Sales

81.11

74.01

63.74

Other Operating Income

0

0

0

Other Income

1.02

0.83

0.62

Total Income

82.13

74.86

64.36

Total Expenditure

71.84

59.9

49.59

PBIDT

10.28

14.96

14.76

Interest

0.85

0.41

0.11

PBDT

9.43

14.53

14.64

Depreciation

1.85

1.47

1.25

Minority Interest Before NP

0

0

0

Tax

1.01

1.99

2.33

Deferred Tax

0.52

0.27

0.25

Reported Profit After Tax

5.86

10.68

10.68

Minority Interest After NP

0

1.02

0.88

Net Profit after Minority Interest

5.86

9.64

9.78

Extra-ordinary Items

-3.57

0

0

Adjusted Profit After Extra-ordinary item

9.44

9.64

9.78

EPS (Unit Curr.)

16.12

32.06

32.54

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

3.52

3

3

Public Shareholding (Number)

9,82,804

9,79,754

9,56,867

Public Shareholding (%)

27.85

32.56

31.8

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

12.68

20.21

23.15

PBDTM(%)

11.63

19.64

22.96

PATM(%)

7.23

14.42

16.75